Literature DB >> 14972791

Metformin attenuates blood lipid peroxidation and potentiates antioxidant defense in high fructose-fed rats.

S Srividhya1, M K Ravichandran, C V Anuradha.   

Abstract

The implication of oxidative stress in the pathology of insulin resistance has been shown recently. We investigated the effect of an insulin sensitizer, metformin, on the plasma lipid peroxidation and antioxidant defense system in the erythrocytes of high fructose fed rats which form an animal model of insulin resistance. The experimental animals were divided into two batches of 12 animals each. The control batch received the control diet, containing starch; the fructose group was given the high fructose diet. At the end of second week these were subdivided into two groups; one was given metformin (50 mg/kg/day in water) by gastric intubation and other group was left untreated. The rats were continued on the same dietary regimen for the next two weeks. Fructose-fed rats showed hyperglycemia, hyperinsulinemia and hypertriglyceridemia at the end of four weeks. Enhanced plasma lipid peroxidation and inadequate cellular antioxidant defense system were observed in them. Administration of metformin was associated with significant normalization of circulating insulin, glucose and triglyceride concentrations. The abnormal triglyceride distribution in the lipoprotein fractions was also ameliorated by metformin therapy. The imbalance between peroxidation and antioxidant defense system was mitigated when fructose-fed rats were treated with metformin. In the control rats, metformin did not affect the parameters studied. Significant positive correlation was obtained between insulin, triglycerides and glucose concentrations with lipid hydroperoxides suggesting that these metabolic variables could influence the lipid peroxide levels in plasma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14972791     DOI: 10.1080/1025814021000024280

Source DB:  PubMed          Journal:  J Biochem Mol Biol Biophys        ISSN: 1025-8140


  7 in total

1.  Role of Pioglitazone with Metformin or Glimepiride on Oxidative Stress-induced Nuclear Damage and Reproductive Toxicity in Diabetic Rats.

Authors:  Syed Imam Rabbani; Kshama Devi; Salma Khanam
Journal:  Malays J Med Sci       Date:  2010-01

2.  Antiglycation and cell protective actions of metformin and glipizide in erythrocytes and monocytes.

Authors:  Krishna Adeshara; Rashmi Tupe
Journal:  Mol Biol Rep       Date:  2016-02-13       Impact factor: 2.316

3.  Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis.

Authors:  Narender Nath; Musfiquidin Khan; Manjeet K Paintlia; Inderjit Singh; Md Nasrul Hoda; Shailendra Giri
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

4.  Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice.

Authors:  Hannah M Kaneb; Paul S Sharp; Nazanin Rahmani-Kondori; Dominic J Wells
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

5.  Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice.

Authors:  Nopporn Thangthaeng; Margaret Rutledge; Jessica M Wong; Philip H Vann; Michael J Forster; Nathalie Sumien
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

6.  Oral Metformin Treatment Counteracts Adipoinsular Axis Dysfunction in Hypothalamic Obese Rats.

Authors:  Daniel Castrogiovanni; Luisina Ongaro; Guillermina Zuburía; Andrés Giovambattista; Eduardo Spinedi
Journal:  Int Sch Res Notices       Date:  2015-04-05

7.  The Impact of Glycemic Status and Metformin Administration on Red Blood Cell Indices and Oxidative Stress in Type 2 Diabetic Patients.

Authors:  Adel Abdel-Moneim; Eman Salah Abdel-Reheim; Margit Semmler; Wessam Addaleel
Journal:  Malays J Med Sci       Date:  2019-08-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.